Literature DB >> 1451146

Ischaemic preconditioning: from mechanisms to exploitation.

D M Walker1, D M Yellon.   

Abstract

Mesh:

Year:  1992        PMID: 1451146     DOI: 10.1093/cvr/26.8.734

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  16 in total

1.  The local intracoronary administration of methylene blue prevents the pronounced antiarrhythmic effect of ischaemic preconditioning.

Authors:  A Vegh; J G Papp; L Szekeres; J Parratt
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

2.  Hypoxic preconditioning in isolated rat hearts: non-involvement of activation of adenosine A1 receptor, Gi protein, and ATP-sensitive K+ channel.

Authors:  K Yabe; Y Nasa; S Takeo
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

3.  Myocardial ischemic preconditioning and mitochondrial F1F0-ATPase activity.

Authors:  F Bosetti; G Yu; R Zucchi; S Ronca-Testoni; G Solaini
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

4.  Ischaemic preconditioning.

Authors:  M Marber; D Walker; D Yellon
Journal:  BMJ       Date:  1994-01-01

Review 5.  Ischaemic preconditioning of myocardium: a new paradigm for clinical cardioprotection?

Authors:  G F Baxter; D M Yellon
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

6.  Reactive oxygen species in early and delayed cardiac adaptation.

Authors:  E Roth; M T Jaberansari
Journal:  Exp Clin Cardiol       Date:  2001

Review 7.  Adaptive and maladaptive mechanisms of cellular priming.

Authors:  D R Meldrum; J C Cleveland; E E Moore; D A Partrick; A Banerjee; A H Harken
Journal:  Ann Surg       Date:  1997-11       Impact factor: 12.969

8.  Development of ischemia/reperfusion tolerance in the rat small intestine. An epithelium-independent event.

Authors:  D L Osborne; T Y Aw; G Cepinskas; P R Kvietys
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

9.  [Ischemic preconditioning in the aged heart--myocardial protective effect as compared with the mature heart].

Authors:  M Uematsu; M Okada
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-09

Review 10.  Preconditioning the human myocardium: recent advances and aspirations for the development of a new means of cardioprotection in clinical practice.

Authors:  D P Jenkins; S E Steare; D M Yellon
Journal:  Cardiovasc Drugs Ther       Date:  1995-12       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.